Royal Bank of Canada increased its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 154.4% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,793 shares of the semiconductor company’s stock after buying an additional 5,944 shares during the quarter. Royal Bank of Canada’s holdings in Axcelis Technologies were worth $912,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Victory Capital Management Inc. grew its holdings in Axcelis Technologies by 85.9% in the 4th quarter. Victory Capital Management Inc. now owns 1,807,404 shares of the semiconductor company’s stock valued at $145,207,000 after buying an additional 835,242 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Axcelis Technologies by 3,402.5% during the 1st quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock worth $45,772,000 after acquiring an additional 477,705 shares during the period. Invesco Ltd. raised its holdings in shares of Axcelis Technologies by 176.6% during the 3rd quarter. Invesco Ltd. now owns 386,735 shares of the semiconductor company’s stock worth $37,761,000 after acquiring an additional 246,939 shares during the period. Balyasny Asset Management L.P. boosted its position in shares of Axcelis Technologies by 10,368.7% during the 4th quarter. Balyasny Asset Management L.P. now owns 243,503 shares of the semiconductor company’s stock valued at $19,563,000 after acquiring an additional 241,177 shares during the last quarter. Finally, Millennium Management LLC boosted its position in shares of Axcelis Technologies by 143.8% during the 3rd quarter. Millennium Management LLC now owns 261,776 shares of the semiconductor company’s stock valued at $25,560,000 after acquiring an additional 154,381 shares during the last quarter. Institutional investors and hedge funds own 89.98% of the company’s stock.
Insider Transactions at Axcelis Technologies
In other news, Director Necip Sayiner sold 1,586 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $157.44, for a total value of $249,699.84. Following the sale, the director directly owned 7,112 shares of the company’s stock, valued at approximately $1,119,713.28. The trade was a 18.23% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Todd Sutton sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $159.99, for a total transaction of $319,980.00. Following the completion of the transaction, the vice president owned 6,360 shares in the company, valued at approximately $1,017,536.40. This represents a 23.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.49% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Report on Axcelis Technologies
Axcelis Technologies Price Performance
NASDAQ:ACLS opened at $127.07 on Friday. Axcelis Technologies, Inc. has a 52 week low of $73.60 and a 52 week high of $193.78. The company has a quick ratio of 3.21, a current ratio of 4.90 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $3.92 billion, a P/E ratio of 42.64, a P/E/G ratio of 3.88 and a beta of 1.92. The stock’s fifty day moving average is $147.33 and its two-hundred day moving average is $127.39.
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.89 by $0.17. The business had revenue of $215.18 million for the quarter, compared to analyst estimates of $205.03 million. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%.The company’s quarterly revenue was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.13 EPS. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. Equities analysts expect that Axcelis Technologies, Inc. will post 3.39 EPS for the current year.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Further Reading
- Five stocks we like better than Axcelis Technologies
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
